When patients arrive at the pharmacy to fill a prescription, they may be unexpectedly told that their insurance company requires additional approval before covering the medication. This process, known as prior authorization, forces healthcare providers to submit extensive paperwork—often delaying treatment for days, weeks, or even months. For individuals living with headache disorders and migraine disease, these delays can mean prolonged pain, reduced quality of life, and increased risk of worsening symptoms.
Prior authorization is intended as a cost-control measure for insurers, but in practice, it creates unnecessary hurdles for patients and healthcare providers. The National Headache Foundation opposes prior authorization policies that limit timely access to medically necessary treatments and burden both patients and clinicians with excessive red tape.